Grand Pharmaceutical Group Limited (stock code: 00512.HK), abbreviated as “Grand Pharma”, is an international pharmaceutical company of technological innovation, integrating pharmaceutical technology, nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision intervention diagnosis and treatment technology and biotechnology.
Currently, the Group has more than 10,000 employees globally, more than 30 subsidiaries at home and abroad, 5 technology platforms and 8 research and development centers, more than 200 products on the National Reimbursement Drug List, and 16 products which worth over 100 million dollars each. The Company has been committed to three major business fields, with its business coverage across various segments including cerebro-cardiovascular, Eye, Nose & Throat (ENT), respiratory and critical and severe diseases, pharmaceutical raw materials, nuclear medicine anti-tumor diagnosis and treatment, cerebro-cardiovascular precision intervention diagnosis and treatment and amino acids.
Grand Pharma has always adhered to the spirit of “dare to be the first and share the success”, with the business philosophy of “provide high-quality products with sincerity and integrity”.
Grand Pharma focuses on the needs of patients, adapts to the market development and take technological innovation as the driving force. In recent years, our Group has successively distributed a series of innovative pharmaceutical products and medical devices products with global markets including the United States, Australia, Germany, Belgium and other countries. Grand Pharma also established the collaborations with world-leading pharmaceutical enterprises, universities and research institutions, and diversified the product pipeline in medical therapeutic field.
“Maintain stable growth, strive in innovation and strategic planning”, Grand Pharma sticks with the development concept of “comprehensive advantages, innovation-oriented and global expansion” and the strategy of “dual-wheel driving development of independent R&D, global expansion and dual-cycle operation”. Our Group has formed a new pattern of domestic and international cycles that synergize with each other, and is committed to becoming an international pharmaceutical company of technological innovation, delivering on its promises for doctors and patients, and making significant contribution to the society.
Established in
Number of member enterprises is
Projects under research
R&D personnel
Benefit both patients and doctors and contribute to the society
Provide high-quality products with sincerity and integrity
Dare to be the first and share the success
Grand journey for a healthier world
· Grand Pharm (China) Company Limited, Preparation Branch · Beijing Huajin Pharmaceutical Co., Ltd. · Hubei Shubang Pharmaceutical Co.,Ltd. · Grand Pharmaceutical Huangshi Feiyun Pharmaceutical Co., Ltd. · Shanghai Xudong Haipu Pharmaceutical Co., Ltd. · Tianjin Tanabe Seiyaku Co., Ltd.
· Hubei Grand Biotechnology Co., Ltd. · Hubei Grand Life Science & Technology Co., Ltd. · Wuhan Grand Hoyo Co., Ltd. · Wuhan Kernel Bio-tech Co., Ltd. · Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd. · Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. · Jiangsu Grand Xianle Pharmaceutical Co., Ltd. · Jiangsu Grand Xinyi Pharmaceutical Co., Ltd. · Cangzhou Huachen BioTech Co., Ltd. · Hebei Grand Jiufu Biochemical Co., Ltd. · Hubei Bafeng Pharmaceuticals & Chemicals Share Co., Ltd.
· Hubei Grand EBE Pharmaceutical Company Limited · Xi’an Beilin Pharmaceutical Co., Ltd. · Tianjin Jingming New Technology Development Co., Ltd. · Chongqing Duoputai Pharmaceutical Co., Ltd.
· Beijing Grand Jiuhe Pharmaceutical Co., Ltd. · Grand Medical Pty Ltd. ·
· Zhu Hai Cardionovum Medical Device Co. Ltd. · Cardionovum GmbH · Conavi Medical Inc. · Changzhou Keyneut Medical Technology Co., Ltd. · CardioNavi MedTech (Wuhan) Co., Ltd.
· Sirtex Medical Pty Ltd. · Shanghai Shetai Medical Technology Limited · Wuhan Shetai Medical Technology Co., Ltd. · Chengdu Shetai Medical Technology Co., Ltd. · Jiangsu Shenming Medical Technology Co., Ltd. · Beijing Purevalley Biotechnology Co., Ltd · Chengdu Purevalley Medical Technology Co., Ltd. · BlackSwan Vascular, Inc.
· Wuhan Wuyao Technology Co., Ltd. · Nanjing AuroRNA Biotech Co., Ltd.
· Wuhan Wuyao Pharmaceutical Co., Ltd. · Lianyungang Jari Pharmaceutical Co., Ltd.
The work on intellectual property rights of Grand Pharma has been commended at the national and provincial levels for many times. Among them, 2 companies were selected as national intellectual property demonstrative companies, 5 companies were selected as national intellectual property advantage companies, 9 companies were selected as provincial and municipal intellectual property demonstrative companies, and 14 companies passed the certification of intellectual property management system. Grand Pharma has won 2 China patent excellence awards, 2 silver awards in Hubei high-value patent competition and a number of Hubei technological invention awards.
Invention Relates to a Traditional Chinese Medicine Composition for Cooling Blood and Hemostasis, Supplementing Yin and Removing Blood Stasis, Nourishing Liver and Brightening Visual Acuity and Preparation Method Thereof
Invention Relates to a Traditional Chinese Medicine Composition for Cooling Blood and Hemostasis, Supplementing Yin and Removing Blood Stasis, Nourishing Liver and Brightening Visual Acuity and Preparation Method Thereof
Corynebacterium Glutamicum Fermentation Medium for Producing L-isoleucine and Its Culture Method
European Patent Application
Japanese Patent Application
U.S.-Patent METHOD FOR PRODUCING TAURINE AND METHOD FOR REMOVING IMPURITY FROM REACTION SYSTEM FOR PRODUCING TAURINE
U.S.-Patent
Method for Producing Taurine and Method for Removing Impurities from Reaction System Prepared by Taurine
Invention Relates to a Self-emulsifying Oral Preparation of Terpene Pharmaceutical Composition, Preparation Method and Application Thereof
Invention Relates to a Traditional Chinese Medicine Composition for Cooling Blood and Hemostasis, Supplementing Yin and Removing Blood Stasis, Nourishing Liver and Brightening Visual Acuity and Preparation Method Thereof
Invention Relates to a Traditional Chinese Medicine Composition for Clearing away Heat and Toxic Materials, Activating Blood Circulation to Dissipate Stasis, Promoting Diuresis and Expelling Phlegm and Preparation Method Thereof
